Drug Profile
hPRL-G129R
Latest Information Update: 20 Jul 2006
Price :
$50
*
At a glance
- Originator Clemson University; Greenville Hospital System
- Class Anterior pituitary hormones; Antineoplastics; Pituitary gonadotropins
- Mechanism of Action Apoptosis stimulants; Prolactin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer